SymBio Pharmaceuticals Limited
Notice Concerning Large-Scale Exercise of the 70th Stock Acquisition Rights (with Exercise Price Adjustment Clause) Issued by Third-Party Allotment
Large-scale exercise of the 70th stock acquisition rights occurred. At the start of the month, the number of shares to be delivered was 8,024,000 shares; exercised rights amounted to 80,240 units (16.7% of the total issued 480,000 units); as of November 5, unexercised units decreased to 328,460 units. The relevant period is November 2–5, 2026.
Key Figures
- Number of shares to be delivered: 8,024,000 shares
- Number of unexercised stock acquisition rights: 328,460 units
- Total number of issued stock acquisition rights: 480,000 units
AI要約
Key Points
A large-scale exercise of the 70th stock acquisition rights issued by third-party allotment occurred. From November 2 to November 5, the total number of shares to be delivered exceeded 800,000 shares; the number of rights actually exercised was 80,240 units, and unexercised units decreased to 328,460 units. During the relevant period, the total number of issued shares was 87,378,960 shares and treasury stock amounted to 91,394 shares.
Market Impact and Outlook
There is potential dilution from the exercise of stock acquisition rights; refer to the main text for the net effect on shares after transfer. It is necessary to reconcile with past disclosed materials and monitor future exercise activity and the movement of treasury stock.
SymBio Pharmaceuticals Limited
Company overview · Stock price · Financial data · All IR
